TASK channels are unusual members of the two-pore domain potassium (K2P) channel family, with unique and unexplained physiological and pharmacological characteristics. TASKs are found in neurons 1,2 , cardiomyocytes 3-5 and vascular smooth muscle cells 6 where they are involved in regulation of heart rate 7 , pulmonary artery tone 6,8 , sleep/wake cycles 9 and responses to volatile anaesthetics 9-12 . K2P channels regulate the resting membrane potential, providing background K + currents controlled by numerous physiological stimuli 13,14 . Unlike other K2P channels, TASK channels have the capacity to bind inhibitors with high affinity, exceptional selectivity and very slow compound washout rates. These characteristics make the TASK channels some of the the most easily druggable potassium channels, and indeed TASK-1 inhibitors are currently in clinical trials for obstructive sleep apnea (OSA) and atrial fibrillation (Afib) 15 (The DOCTOS and SANDMAN Trials). Generally, potassium channels have an intramembrane vestibule with a selectivity filter above and a gate with four parallel helices below. However, K2P channels studied to date all lack a lower gate. Here we present the structure of TASK-1, revealing a unique lower gate created by interaction of the two crossed Cterminal M4 transmembrane helices at the vestibule entrance, which we designate as an "X-gate". This structure is formed by six residues (V 243 LRFMT 248 ) that are essential for responses to volatile anaesthetics 11 , neuro-transmitters 16 and G-protein coupled receptors 16 . Interestingly, mutations within the X-gate and surrounding regions drastically affect both open probability and activation by anaesthetics. Structures of TASK-1 with two novel, high-affinity blockers, shows both inhibitors bound below the selectivity filter, trapped in the vestibule by the X-gate, thus explaining their exceptionally low wash-out rates. Thus, the presence of the X-gate in TASK channels explains many aspects of their unusual physiological and pharmacological behaviour, which is invaluable for future development and optimization of TASK modulators for treatment of heart, lung and sleep disorders.
To understand the molecular basis of the unusual properties of TASK channels we solved the structure of human TWIK-related acid-sensitive potassium channel 1 (TASK-1, K2P3.1) by X-ray crystallography. We used a C-terminally truncated construct (Met1 to Glu259) for the structural studies, which had similar properties to the full-length channel, in particular its response to the pore-blockers A1899 and ML365, and its activation by pH (Extended Data Fig. 1 ). We grew crystals using the HiLiDe method 17 and determined the structure by molecular replacement using X-ray data to 3.0 Å resolution (Methods, Extended Data Table 1 , Fig. 1 , Extended Data Fig. 2a-f ). TASK-1 forms a domain-swapped homodimer ( Fig. 1a) , with a pseudo-tetrameric selectivity filter, four transmembrane helices (M1-M4) and an extracellular cap, similar to previously solved structures of other K2P channels [18] [19] [20] [21] [22] (Fig. 1b) .
The selectivity filter resembles that of other K2P channels, with binding sites for four K + ions.
TASK-1 is inactivated by extracellular acidic pHs 23 (Extended Data Fig. 1c ) and His98, near the top of the selectivity filter, is thought to be the extracellular pH sensor 24 . Crystals were grown at pH 8.5 and the structure shows His98 forming a hydrogen bond to a water molecule behind the selectivity filter (Extended Data Fig. 2c ). His98 is positioned below the sidechains of Gln77 and Gln209, which interact with each other, so that in this conformation it cannot access the extracellular space. It has been proposed that protonation of His98 could lead to reorientation of the sidechain into the extracellular space 25 , which would also require disruption of the Gln77-Gln209 interaction.
One unusual feature of the TASK and THIK channels is the absence of the intermolecular disulphide bond at the apex of the external cap domain (Extended Data Fig. 3b ).
However, we found that in TASK-1 the domain-swapped cap structure is preserved without this disulphide bond (Extended Data Fig. 2e -h), as previously predicted 26 . Therefore, this feature does not explain the differences in TASK-1 properties. The relative positions of the M2-M4 helices determine whether stretch-activated K2P channels are in a more active "up" state with raised helices and closed fenestrations, or a lower activity "down" state with open fenestrations 20, 21 . Overall the TASK-1 structure adopts a "down"-like state, with some adjustment of the M2 position and open fenestrations connecting the small central vestibule to the lipid bilayer ( Fig. 1b-d) .
Surprisingly, we found that at the distal end of M4 there was an unexpected conformational rearrangement, causing the M4 helices to lie across the entrance of the vestibule, forming a closed gate which we have designated as an "X-gate" (Fig. 1c-h ). This conformational change is caused by bends in M4 at residues Leu241 and Asn250, on either side of a six residue sequence (V 243 LRFMT 248 ) which forms the X-gate. This leaves a gap of 2-3 Å between the M4 helices, in contrast to TREK-2 which has a gap of at least 7.5 Å (Fig.   1e ,f). The X-gate adopts an unusual extended two-turn helical structure, lacking the hydrogen bonding patterns seen in α or 310 helices (Extended Data Fig. 2i ). The interface is lined by the hydrophobic sidechains of Leu244, Met247 and the methyl group of Thr248 (Fig. 1g,h) , which block the ion conduction pathway. Interestingly, this region is essential for TASK-1 responses to volatile anaesthetics [9] [10] [11] [12] , neurotransmitters 16 , drugs 27 and G-protein coupled receptors 16 (potentially through diacylglycerol 28 or PIP2 interactions 29 ). Sequence alignments suggest TASK-3 and TASK-5 may also form similar structures (Extended Data Fig. 3 ). The presence of the X-gate in the TASK subfamily is an exception to the paradigm that K2P channels lack a lower gate 30 . Surprisingly, the structure of the dimeric X-gate is unrelated to the 'helix bundle crossing' gates found in tetrameric K + channels, which have four parallel helices forming a funnel shape.
To determine whether the X-gate explains the unusual properties of TASK channels, we performed alanine scanning mutagenesis across the distal M4 helix (Thr230-Thr248), and assessed channel activity and surface expression of the mutants. We predicted that disruption of the X-gate would increase the very low TASK-1 basal channel activity 7, 30, 31 . Strikingly, mutation of any residue within the X-gate (except Val243), led to increased currents ( Fig. 2a ), which were not caused by increased surface expression, as we observed similar or reduced surface expression (Extended Data Fig. 4a ). The centre of the X-gate is formed by Leu244, which is packed between residues on M2, M4 and M4' (Fig. 1h,2b ) and the Val244A mutation resulted in the largest current increase ( Fig. 2a ). Inside out single channel recordings of Leu244Ala confirmed a direct effect on channel gating with a 6-fold increase in channel open probability from 0.7 to 4.0% ( Fig. 2c,d) and increased channel open times ( Fig. 2e ). Mutation of the equivalent residue in TASK-3 (Leu244Ala) also resulted in increased channel activity ( Fig. 2f ). The X-gate is also important for activation by volatile anaesthetics such as halothane and sevoflurane 9-12 , and was originally called the "halothane response element". Here we confirm that sevoflurane, a modern and widely used anaesthetic, also activates TASK-1 and that mutations in the X-gate reduces this activation ( Fig. 2g,h) , indicating a role for the X-gate in responses to volatile anaesthetics.
Next we investigated residues surrounding the X-gate, which may be important for its formation and stability. The X-gate is preceded by a hinge point in M4 around Leu241-Val242, where the helix axis is bent by ~40° ( Fig. 3a) . After the bend the X-gate itself adopts an expanded helical conformation (Extended Data Fig. 2i ). The side chain of Leu241 inserts into a hydrophobic pocket, pulling it away from the helix axis and stabilizing the bend in M4. This exposes the Leu241 carbonyl so that it can hydrogen bond with the Arg245 sidechain ( Fig. 3a ).
Mutation of either Leu241 or Arg245 to Ala increased channel activity by 5-7 fold ( Fig. 2a ), confirming the importance of these interactions in X-gate stability. Furthermore, a hydrogen bond between the carbonyl oxygen of Ala237 on M4 and Asn133 on M2 also disrupts the M4 α helix, stabilizing the bend, and mutation of Asn133 increased channel activity (Fig. 3b ).
Following the X-gate, a second bend in M4 at residue Asn250 allows the distal end of M4 to adopt an α-helical structure which forms extensive interactions with the opposite side of the vestibule, a region we have named the "latch" (Fig. 3a ). This consists of an extensive network of salt bridges and hydrogen bonds linking M4 to M1 and M2' (Fig. 3a ). Mutation of several residues across the proximal M1, distal M2' and distal M4 regions gave increased channel activity, consistent with the latch region playing an important role in stabilizing the Xgate ( Fig. 3b ). In particular, Arg7 and Arg131' appear to be important for the integrity of the latch, since mutations to acidic residues causes a 5 -10 fold increase in currents (Fig. 3c ). The reduced levels of surface expression for these mutants indicates their increased currents are likely due to direct effects on channel gating, not increased surface expression (Extended data Fig. 4b ).
Lipids are also important regulators of K2P channels and the structures reveal binding sites for lipids, including the cholesterol analogue cholesteryl hemisuccinate (CHS) (Extended Data Fig. 2d ). CHS (added during TASK-1 purification) extends along the X-gate, interacting with M1, M4 and M2' (Fig. 3a ). Phe246 in the X-gate lies next to the CHS molecule ( Fig. 3a) , and the Phe246Ala mutation produces a 4-fold increase in current ( Fig. 2a ). Therefore, cholesterol may also help to stabilize the X-gate in a closed conformation.
Unlike many other K2P channels that exhibit very poor pharmacology, several high affinity and highly selective inhibitors exist for TASK-1 and TASK-3 channels. Furthermore, these blockers exhibit exceptionally low wash-out rates after removal of the inhibitor.
Together, these characteristics make TASK inhibitors interesting pharmacological tools to investigate the physiological and pharmacological function of TASK channels. Therefore, we performed an ultra-high throughput screen (uHTS) on TASK-1, which identified two highly potent and selective inhibitors of TASK-1, BAY 1000493 and BAY 2341237 ( Fig. 4a,b) , with EC50 values of 9.5 and 7.6 nM. Crystal structures of complexes of TASK-1 with these inhibitors showed that they both bind within the inner vestibule, directly below the selectivity filter ( Fig. 5a,d) , as expected. This arrangement was confirmed using anomalous difference maps with data collected at the Br absorption edge (Extended Data Fig. 5a ). In contrast, BAY 2341237 only binds in one orientation, with 100% occupancy, due to small differences in the two chains of the dimer (Fig. 4d ,f,g, Extended Data Fig. 5b,e ).
Both inhibitors bind to the closed conformation of TASK-1, below the selectivity filter, without perturbing the X-gate structure. They fit precisely to the surface at the top of the vestibule, with Leu122 projecting into the vestibule below the compounds, holding them in place ( Fig. 4e -g). Consistent with these observations, we found that mutation of residues lining the inhibitor binding site (Thr93Cys, Ile118Ala, Leu122Ala, Thr199Cys and Leu239Ala) drastically reduced inhibition by BAY 1000493 (Fig. 4h ). Leu122 is important for binding of other TASK-1 pore blockers 27,32 and it occupies a key position below the binding site for our inhibitors (Fig. 4g ). When we recorded full dose-response curves with TASK-1 and a Leu122Ala mutant, we found a >100-fold decrease in EC50 values for both inhibitors with the mutation (Fig 4i) . In addition, we found that BAY 1000493 is highly selective for TASK-1 and TASK-3, when compared to a wide range of other ion channels (Extended Data Fig. 6a ,b, Extended Data Table 2 ).
Our structures show that both compounds bind at the top of the vestibule, trapped but not in direct contact with the X-gate. Leu244 is central to the X-gate structure, but is not part of the inhibitor binding site and a Leu244Ala mutation did not alter inhibition by BAY 1000493 ( Fig. 4h ). However, TASK channels have another critical feature, their ability to retain bound compounds for long periods during washout experiments. BAY 1000493 shows very slow washout rates from TASK-1 ( Fig. 4j , Extended Data Fig. 6c ), unlike a larger TASK inhibitor, A1899, which has an IC50 value of 35 nM and washes off significantly faster 27 (Extended Data Fig. 6d-f ). When the Leu244Ala mutation is introduced at the X-gate or the Arg131Asp mutation at the latch, we observed a significant increases in the BAY 1000493 washout rate ( Fig. 4j ,k, Extended Data Fig. 6c ). Conversely, a mutation near the latch (Thr134Cys), that has relatively little effect on X-gate function (Fig. 3b ), also has less effect on washout rates ( Fig., 4j, Extended Data Fig. 6c ). This suggests that disruption of the X-gate or the latch may stabilise the open state of the channel, thereby allowing BAY 1000493 to dissociate more easily from this site.
The X-gate must be capable of opening wide enough to allow inhibitors to enter, as well as hydrated K + ions. Therefore, it is likely that X-gate opening requires a significant conformational change, not simply small adjustments in sidechain positions or helix orientation. We speculate that this could involve opening of the latch, relaxation of the X-gate extended helix into an α-helical conformation and straightening of M4 (Extended Data Fig. 7) , giving a conformation similar to other K2P structures [18] [19] [20] [21] [22] . This would also allow the M1-M4 helices to adopt a more "up"-like conformation, without fenestrations, consistent with the proposed higher activity state of other K2Ps (Extended Data Fig. 7 ). ). These mutations emphasize the significance of these regions in TASK channel function.
Loss of function (LoF
In conclusion, we have shown that the TASKs channels are highly unusual members of the K2P channel family in that they have the ability to form a cytoplasmic X-gate, which may contribute to the low open probability of TASK-1. We have also shown that two nanomolar affinity inhibitors bind in the closed vestibule, trapped by the X-gate. Their precise fit to the top surface of the vestibule, combined with the trapping effect of the X-gate may explain the exceptionally high affinity and selectivity observed with these pore blockers. In addition, the presence of the X-gate may also explain the very low wash-out rates of these inhibitors.
Compound trapping within the inner cavity has been proposed previously for many ion channels [36] [37] [38] [39] . TASK-1 inhibitor binding requires opening of the X-gate, allowing compounds to enter and bind to the high affinity site below the selectivity filter. Since the X-gate is closed most of the time and there is little space for the compound to dissociate, they will remain bound, trapped by the X-gate, resulting in an increased apparent affinity and reduced washout rate.
However, whether the open state of TASK-1 involves any change in the conformation of the compound binding site, or whether these compounds can stabilize the X-gate in its closed conformation, remains to be seen.
The X-gate is clearly important for the control of TASK channel activity and may contribute to their regulation by neurotransmitters 16 , intracellular signalling pathways 16, 28, 29 , volatile anaesthetics [9] [10] [11] [12] and small molecules 27 . However, given the polymodal nature of K2P channel regulation and the known role of the selectivity filter in K2P channel gating, the X-gate is unlikely to be the only route for TASK channel regulation. For example, their physiologically relevant regulation by extracellular pH involves His98, which is extracellular, located next to the selectivity filter. Further studies are needed to determine if these two gating mechanisms are coupled.
This study also provides insight into the mechanism of TASK-1 inhibitors that are already in clinical trials as potential treatments for obstructive sleep apnea and atrial fibrillation. The unique environment of the inhibitor binding site within the vestibule, created by the X-gate, has significant implications for interpretation of pharmacokinetic properties of TASK inhibitors. In particular, questions of bioavailability, metabolism and half-life should be interpreted in the light of the discovery of the X-gate. Once a blocker becomes sequestered within this vestibule, it is likely to remain bound and 'active' for much longer than anticipated by studying its pharmacokinetic properties. Such factors should be carefully evaluated during drug development and trials. Overall, this work provides critical understanding of the gating mechanism in TASK channels and the action of clinically-relevant inhibitors, processes that are of uppermost importance for their use as targets for efficient and safe treatment of disease.
Methods

Cloning and expression of TASK-1 Met1-Glu259 for structural studies
The human KCNK3 gene (Genbank ID 4504849), which encoded the TASK-1 protein, was obtained from Origene. The TASK-1 construct, residues Met1 to Glu259, was subcloned in the SGC vector pFB-CT10HF-LIC, with a C terminal TEV site followed by decahistidine and FLAG tags. Baculovirus was generated with the Bac-to-bac system and passaged twice before it was used for infecting Sf9 cells at a density of 2 x 10 6 cells/mL and a ratio of 5 mL virus per litre cells. Infected cells were harvested after 72 h by centrifugation, frozen in liquid nitrogen and stored at -80℃.
Purification of TASK-1
Cells were broken with an EmulsiFlex-C3 or C5 high-pressure homogenizer (Avestin A full dataset for the BAY 1000493 complex was assembled from several 40° wedges from one crystal whereas the BAY 2341237 dataset was collected as a single wedge, both with a 20x20 µm beam. Anomalous data for BAY 1000493 were collected at the bromine edge, (λ = 0.9116 Å) in four 360° passes.
Model building and refinement for structures
Data were processed as individual wedges in XDS 40 and scaled together in XSCALE 40 .
The data were merged in AIMLESS 41,42 (Extended Data Table 1 ). Due to the anisotropy of the data, an anisotropic cut-off was applied using the STARANISO server 43 . The structure was solved using molecular replacement with Phaser, using a truncated model of TREK-2 21 (PDB ID: 4BW5) with separate search models consisting of the TM domain and the cap. Two copies of the TASK-1 dimer were located in the asymmetric unit. An initial TASK-1 model was built using a density modified prime-and-switch map calculated using phenix.autobuild 44 as a guide and was improved by several rounds of manual model building and refinement in COOT 45 .
Refinement was carried out in BUSTER version 2.10.3 46 , using all data to 3.0 Å in the highest resolved direction, with NCS restraints and one TLS group per chain. Four potassium ions per homodimer were modelled and distances from the oxygen atoms in the filter were restrained to 2.8 Å. The final model for the native structure comprised residues Met1 to Asp257 in chains A and C, and Met1 to Leu261 in chains B and D. In the AB dimer, residues 149 to 151 are disordered and were not modelled. The selectivity filter of TASK-1 consists of residues T 93 IGY 96 and T 199 IGF 202 from each subunit, and they adopt the expected conformation seen in other K2P structures [18] [19] [20] [21] [22] . The carbonyl oxygens of these residues, as well as the sidechain oxygens of Thr93 and Thr199, coordinate four K + ions in sites S1-S4 ( Fig. 1c,d , Extended Data Fig. 2a-d ). However, there is weaker density for the S2 K + ion and it refines to have a higher B factor in all structures, compared to the three other K + ions. Omitting this K + ion altogether resulted in a positive Fo-Fc peak, so it was included in the model, with 100% occupancy and a higher B factor.
The structure contains a well-defined CHS molecule packed against the X-gate. It lies in an extensive, largely hydrophobic groove formed by residues Arg3, Arg7, Pro119, Val123, Val243, Phe246 and Met249. The two arginine residues are adjacent to the hemisuccinate moiety whereas the hydrophobic residues are adjacent to the cholesterol unit.
Data for the ligand complexes were processed in the same way as the native complex (Extended Data Table 1) to 2.9 Å and 3.1 Å for BAY 1000493 and BAY 2341237, respectively.
After one round of refinement in BUSTER version 2.10.3 46 , positive difference density was apparent in the vestibule. For BAY 1000493, an anomalous difference map was calculated in PHENIX 44 , revealing two Br peaks per dimer. Since BAY 1000493 binds across the dimer axis below the selectivity filter, only one copy of the inhibitor is bound per TASK-1 dimer. In the case of BAY 1000493, the dimer is symmetrical, and the inhibitor binds in either orientation with a 50% probability, so the density in the pore is the average of the two possible orientations throughtout the crystal. However, each dimer has one molecule of BAY 1000493 bound and it only binds in one position, with the same interactions regardless of the orientation. In contrast,
The Fo-Fc difference density map calculated with BAY 2341237 omitted from the structure, revealed a single conformation for the compound, which was modelled with 100% occupancy. This is the result of BAY 2341237 inducing some small degree of asymmetry into the dimer, resulting in the dimer/inhibitor complex packing in only one orientation in the crystal. The final models were refined against the anisotropically truncated STARANISO 43 data.
Two-electrode voltage-clamp measurements
X. laevis oocytes were obtained and the TEVC measurements were recorded as described previously 27 . Briefly, collected oocytes were stored at 18 °C in ND96 solution (in mM: NaCl 96, KCl 2, CaCl2 1.8, MgCl2 1, HEPES 5 and pH 7.5) supplemented with 50 mg/l gentamycin, 274 mg/l sodium pyruvate and 88 mg/l theophylline. Oocytes were injected with 5 ng of TASK-1 cRNA and incubated for 48 h at 18 ℃. ND96 was used as recording solution.
Oocytes were held at -80 mV and voltage was ramped from -120 to +45 mV within 3. 
Chemiluminescence assay in X. laevis oocytes
Surface expression of TASK-1 channel constructs was studied as previously described 47 . Briefly, X. laevis oocytes were injected with cRNA of HA-tagged channels. After 48h, oocytes were incubated in ND96 plus 1 % BSA on ice for 30 min to reduce unspecific antibody binding. Subsequently, the oocytes were incubated with primary antibody (rat anti-HA (Roche), 1:100) for 1 h, and after extensive washing they were incubated with secondary antibody (goat anti-rat-IgG, HRP-coupled (Dianova), 1:500) for 1 h. After oocytes were individually placed into a vial with 20 µl of luminescence substrate (SuperSignal Femto (Thermo Scientific)), light emission was detected with a GloMax luminometer (Promega).
Single channel measurements
Inside-out single channel patch clamp recordings of Xenopus oocytes were performed similar as previously described 31 
Quantification and statistical analysis
Quantification and the statistical analysis of the data were executed as previously 
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